Answers are grounded in this paper and cite their sources.
A number of indazol‐3‐ol and indazolin‐3‐one derivatives were designed as open‐chain analogues of some previously studied cytostatic tetranuclear indazolinones. The former were prepared by starting with alkylation of the parent indazolinones ( 11 or its 5‐H analogue). Special mention deserves the method we developed for the direct alkylation of position 2 of indazolinone 11 with benzyl or picolyl halides. The prepared compounds were evaluated as cytostatic agents against HeLa cells, but only 1‐benzylindazolol 5a and 1‐(2‐fluorobenzyl)‐3‐methoxy‐ and 1‐benzyl‐3‐methoxyindazoles 14h , i display significant activity. Additional 13 C‐NMR studies and conformational analysis using molecular mechanics and quantum‐mechanical semiempirical techniques confirm that the compounds designed as analogues of the model cytostatic indazolinones are not able to mimic effectively the structural features of the latter.
No takes yet. Share an insight, caveat, or question.
Arán et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: